Filing Details

Accession Number:
0001437749-21-010969
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-05 13:00:00
Reporting Period:
2021-05-03
Accepted Time:
2021-05-05 19:22:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158895 Lemaitre Vascular Inc LMAT Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365737 W George Lemaitre C/O Lemaitre Vascular, Inc.
63 Second Avenue
Burlington MA 01803
Chairman And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-03 25,000 $51.31 0 No 4 S Indirect See footnote 1.
Common Stock Disposition 2021-05-04 24,888 $51.62 2,667,945 No 4 S Direct
Common Stock Disposition 2021-05-05 31,576 $51.68 2,636,369 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote 1.
No 4 S Direct
No 4 S Direct
Footnotes
  1. These shares were sold by LeMaitre Family LLC. LeMaitre Family LLC is 100% owned by the LeMaitre 2003 Children's Trust. Christopher Lynch and the Reporting Person serve as co-trustees for the LeMaitre 2003 Children's Trust, which was formed for the benefit of the children of George D. LeMaitre, the Issuer's founder, and Cornelia W. LeMaitre. The Reporting Person disclaims ownership of the securities transacted and/or held by LeMaitre Family LLC except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.
  2. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $50.54 to $53.07. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  3. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $51.25 to $51.94. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  4. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $50.49 to $52.18. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.